Armstrong AJ, et al. Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial. ASCO-GU 2019, abstract 29.
Androgeendeprivatietherapie beschermt mogelijk tegen infectie met SARS-CoV-2
jul 2020 | Uro-oncologie, Virale infecties